| Drawing the Study |
| Research is adequate |
22 |
100 |
| The epidemiological source is stated |
22 |
100 |
| The study is identified as an economic evaluation |
22 |
100 |
| Provide a structured summary |
13 |
60 |
| Describe characteristics of population |
13 |
60 |
| Time horizon |
11 |
50 |
| Study perspective |
17 |
80 |
| The form of economic evaluation used is stated |
14 |
64 |
| The study was approved by an institution authorized in ethics in research |
20 |
91 |
| Conflicts of interest |
12 |
55 |
| Study funded |
13 |
59 |
| Data Collection |
| The source(s) of costs estimates used are stated |
19 |
86 |
| The costs were clearly described |
19 |
86 |
| The valuation method is stated |
12 |
55 |
| Type of cost is stated |
22 |
100 |
| Currency, price date, and conversion |
11 |
50 |
| Unit costs are described in |
11 |
50 |
| The analytical model used is stated |
11 |
50 |
| Methods and assumptions for extrapolating results |
11 |
50 |
| The measurement of costs is adequate |
18 |
81 |
| Analysis and Interpretation of the Results |
| Evidence of quality |
18 |
81 |
| Characterizing uncertainty |
11 |
50 |
| Outcome measures in health were clearly described, relevant to the study question |
19 |
86 |
| Ratio between health costs and outcomes |
13 |
59 |
| The approach to sensitivity analysis is given |
13 |
59 |
| Relevant aspects |
11 |
50 |
| The variation of costs over time is justified |
13 |
59 |
| Conclusions follow from the data reported |
21 |
95 |
| Conclusions are accompanied by the appropriate caveats |
20 |
91 |
